What Researchers Did
Researchers reported a case of symptomatic scleroderma-related pneumatosis intestinalis that responded clinically to hyperbaric oxygen therapy.
What They Found
They found that a patient with symptomatic scleroderma-related pneumatosis intestinalis, associated with pneumoperitoneum and ileus, showed clinical improvement after receiving hyperbaric oxygen therapy. This successful outcome suggests hyperbaric oxygen therapy may be a viable treatment option for similar cases.
What This Means for Canadian Patients
Canadian patients experiencing symptomatic pneumatosis intestinalis, especially those with underlying conditions like scleroderma, might benefit from considering hyperbaric oxygen therapy as a treatment option. This therapy could potentially offer relief for a condition that can range from asymptomatic to severe bowel obstruction.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
As a case report, the findings are limited to a single patient and cannot be generalized to a broader patient population.